Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice'

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorDuke-NUS Graduate Medical School

About this trial

'My Voice' is a website intervention developed to enable advance care planning (ACP) conversations for patients with kidney disease on dialysis, educate patients on their illness, help identify their goals and preferences for EOL care, and coaches them on how to speak with their HCPs and loved ones. This study aims to evaluate if 'My Voice' intervention improves quality of ACP conversations between patients and providers, and patients and family carers; improves patient's knowledge about kidney failure, engagement in ACP and preparedness for future end of life care compared to usual practices for ACP in dialysis centres.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Singapore citizens or permanent residents; aged 21 years (age of majority) or older

CKD stage 5; receiving dialysis

clinical deterioration with a terminal condition or

intolerability to dialysis or

Disqualifiers

Patients with cognitive impairment or serious mental illness will be excluded

Patients who had prior serious illness conversations (SIC) will be excluded

Are not easily contactable via mobile phone or landline

Those who are foreign domestic workers/maids

Trial design

Design model

Parallel

Treatments tested in this trial

  • My Voice website intervention with patient and caregiver modules

    Other intervention

    'My Voice' is an interactive web-based ACP intervention tailored for patients with kidney failure on dialysis, and their caregivers, and includes patient and caregiver modules. Patient module has 6 steps consisting of a series of videos, value-clarification exercise (VCE) identifying goals and values for care, and knowledge quiz, and a summary My Voice document that is generated shared with patients, designated surrogates and HCPs. Automated reminders are sent to revisit My Voice. Caregiver module has 4 steps with videos and quiz, with access to their loved one's summary My Voice document containing goals of care and values.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Intervention groupExperimental treatment 1 intervention
Group B: Usual care groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Quality of ACP conversations (serious illness conversations) between patients and physicians/health care providers

Quality of ACP conversations will be measured using a scoring sheet developed for the study. One point will be given for every SICG topic discussed with score min to max of 0 to 13. Higher scores indicate higher quality.

Time frame
Post baseline and within 8 weeks

Secondary outcomes

Other outcomes

1

Change in kidney disease and dialysis knowledge scores

Collected using knowledge questions designed by the research team. Higher scores indicate higher knowledge

Time frame
Baseline to 8 weeks
2

Change in ACP engagement

Using the 9-item Advance care planning engagement scale. 9 to 45 (Min to Max) value, with higher value indicating higher engagement

Time frame
Baseline to 8 weeks
3

Change in patient preparedness

Assessed using Preparedness for end-of-life decision-making scale. 20 to 80 (min to max) scores, with higher scores indicating better preparedness

Time frame
Baseline to 8 weeks
4

Change in proportion of patients who had ACP conversations with family caregivers/spokesperson

Based on self-reported number of ACP conversations collected in the survey

Time frame
Baseline and 8 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Duke-NUS Graduate Medical School

Lead sponsor

National Kidney Foundation, Singapore

Collaborator